Randy Brenner
Algemeen Adviseur bij PARATEK PHARMACEUTICALS, INC.
Profiel
Randy Brenner is currently the Chief Development & Regulatory Officer at Paratek Pharmaceuticals, Inc. He previously worked at Pfizer Inc. as the Vice President-Established Products Business Units from 2010 to 2011.
He also worked at Shire Plc as the Head-Regulatory Affairs.
Mr. Brenner completed his undergraduate degree at Muhlenberg College and his graduate degree at Temple University School of Pharmacy.
Actieve functies van Randy Brenner
| Bedrijven | Functie | Begin |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Algemeen Adviseur | 03-06-2015 |
Eerdere bekende functies van Randy Brenner
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01-09-2011 |
| SHIRE | Corporate Officer/Principal | - |
Opleiding van Randy Brenner
| Muhlenberg College | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |